Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2750425)

Published in AAPS PharmSciTech on December 14, 2007

Authors

Mohd Aftab Alam1, Farhan Jalees Ahmad, Zeenat Iqbal Khan, Roop Krishen Khar, Mushir Ali

Author Affiliations

1: Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi-110062, India. afealam@rediffmail.com

Articles by these authors

Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm (2006) 1.59

Design and evaluation of bilayer floating tablets of captopril. Acta Pharm (2006) 1.41

Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech (2007) 1.39

Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces (2009) 1.22

Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav (2004) 1.13

Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech (2010) 1.12

Gold nanoparticles in theranostic oncology: current state-of-the-art. Expert Opin Drug Deliv (2012) 0.99

Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets (2012) 0.96

Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech (2006) 0.96

Stability indicating HPTLC method for determination of terbutaline sulfate in bulk and from submicronized dry powder inhalers. Anal Sci (2010) 0.94

Reassessing bioavailability of silymarin. Altern Med Rev (2011) 0.94

Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm (2010) 0.91

Nanometric gold in cancer nanotechnology: current status and future prospect. J Pharm Pharmacol (2012) 0.90

Amiloride protects against pentylenetetrazole-induced kindling in mice. Br J Pharmacol (2005) 0.88

Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm (2009) 0.88

Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm (2008) 0.88

Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des (2010) 0.87

The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review. Expert Opin Ther Pat (2011) 0.86

Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J Drug Target (2010) 0.86

Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron. AAPS PharmSciTech (2009) 0.86

Metallic nanoparticles: technology overview & drug delivery applications in oncology. Expert Opin Drug Deliv (2010) 0.86

Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel. AAPS PharmSciTech (2011) 0.86

Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions. Eur J Pharm Biopharm (2008) 0.86

Colonic drug delivery: an updated review. AAPS PharmSci (2003) 0.84

A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke. Protoplasma (2013) 0.83

Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation. Pharm Dev Technol (2008) 0.83

In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol (2008) 0.83

Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets (2013) 0.81

Edetate calcium disodium nanoparticle dry powder inhalation: a novel approach against heavy metal decorporation. Int J Pharm (2011) 0.81

Novel buccal adhesive system for anti-hypertensive agent nimodipine. Pharm Dev Technol (2010) 0.81

Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis. J Microencapsul (2012) 0.81

Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm (2013) 0.81

Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm (2010) 0.81

Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Deliv (2010) 0.81

Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. Curr Pharm Des (2011) 0.80

Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles. Drug Test Anal (2013) 0.79

3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol (2010) 0.78

Development, characterisation and pharmacoscintigraphic evaluation of nano-fluticasone propionate dry powder inhalation as potential antidote against inhaled toxic gases. J Microencapsul (2013) 0.78

Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opin Drug Deliv (2013) 0.78

Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies. Nanotechnology (2013) 0.77

Omega-3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. Curr Drug Targets (2013) 0.77

Development of nano alpha-ketoglutarate nebulization formulation and its pharmacokinetic and safety evaluation in healthy human volunteers for cyanide poisoning. Environ Toxicol Pharmacol (2011) 0.77

Potential of microemulsions in drug delivery and therapeutics: a patent review. Recent Pat Drug Deliv Formul (2008) 0.77

Application of decoy oligonucleotides as novel therapeutic strategy: a contemporary overview. Curr Drug Discov Technol (2013) 0.77

Pulmonary delivery of nanosized alendronate for decorporation of inhaled heavy metals: formulation development, characterization and gamma scintigraphic evaluation. Pharm Dev Technol (2013) 0.77

Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res (2012) 0.76

Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate. Yakugaku Zasshi (2008) 0.76

Patents on nanoparticulate drug delivery systems--a review. Recent Pat Drug Deliv Formul (2008) 0.76

In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting. Expert Opin Drug Deliv (2012) 0.76

Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues. Curr Drug Metab (2015) 0.75

Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi. Parasitol Res (2013) 0.75

Solid Matrix Based Lipidic Nanoparticles in Oral Cancer Chemotherapy: Applications and Pharmacokinetics. Curr Drug Metab (2015) 0.75

Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy. Expert Opin Drug Deliv (2014) 0.75

Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences. J Drug Target (2013) 0.75

Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension. Drug Deliv (2010) 0.75

Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation. Drug Dev Ind Pharm (2012) 0.75

Formulation and optimization of Candesartan Cilexetil Nano Lipid Carrier: in-vitro and in-vivo evaluation. Curr Drug Deliv (2016) 0.75

Feasibility of Assam Bora rice starch as a compression coat of 5-fluorouracil core tablet for colorectal cancer. Curr Drug Deliv (2012) 0.75

Patented bioavailability enhancement techniques of silymarin. Recent Pat Drug Deliv Formul (2010) 0.75

Development of polysaccharide based colon targeted drug delivery system: design and evaluation of Assam Bora rice starch based matrix tablet. Curr Drug Deliv (2011) 0.75

Development and validation of a stability-indicating method for determination of free sterols in the Asian medicinal leech Hirudo manillensis. J Chromatogr Sci (2012) 0.75

Retracted An HPTLC method for the determination of minocycline in human plasma, saliva, and gingival fluid after single step liquid extraction. Anal Sci (2009) 0.75

Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv (2013) 0.75

Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm (2012) 0.75

Retracted Antileishmanial activity of nanocurcumin. Ther Deliv (2011) 0.75

Validated stability-indicating densitometric thin-layer chromatography: application to stress degradation studies of minocycline. Anal Chim Acta (2007) 0.75

Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability. Drug Dev Ind Pharm (2014) 0.75

In vivo lung deposition and sub-acute inhalation toxicity studies of nano-sized alendronate sodium as an antidote for inhaled toxic substances in Sprague Dawley rats. Environ Toxicol Pharmacol (2013) 0.75